Intensive work is being carried out around the world to combat the Corona virus (COVID-19). On the one hand, while the development of vaccines continues, on the other hand, it is aimed to stop the epidemic as soon as possible by increasing the production of all needs from the mask to the respirator.
Bosch developed rapid test for corona virus
Test kits are critical to detect virus infections in a short time. In this context, Bosch Healthcare Solutions, Randox Laboratories Ltd. Along with, it developed one of the world’s first fully automated molecular diagnostic tests.
This kit, which meets the requirements of the World Health Organization (WHO), can simultaneously diagnose 10 respiratory pathogens for differential diagnosis. The rapid molecular diagnostic test runs on the Vivalytic analyzer from Bosch Healthcare Solutions.
The rapid test, developed in just six weeks, can detect COVID-19 infection in patients in less than 2.5 hours from the time the sample is taken until the result is reached. Another advantage of the rapid test is that it can be done directly at the point of care. This eliminates the need to move samples, a time that can be considered valuable.
It also means that patients get precise information about their health more quickly, and that infected people are instantly identified and quarantined. The rapid test of Bosch is one of the world’s first fully automated molecular diagnostic tests that can be used directly by all healthcare institutions. It allows testing a single sample not only for COVID-19, but also for 9 different respiratory diseases, including influenza A and B.